MAPT and Alzheimer disease: The link between sTREM2 levels in the CSF and other AD biomarkers is the subject of another investigation in which CSF sTREM2 levels were strongly correlated with CSF T-tau and P-tau but not with βA42 in 101 individuals with either amyloid-positive or amyloid-negative status.